119 related articles for article (PubMed ID: 2677365)
41. Terconazole. Pharmacology of a new antimycotic agent.
Cauwenbergh G; Vanden Bossche H
J Reprod Med; 1989 Aug; 34(8 Suppl):588-92. PubMed ID: 2677363
[TBL] [Abstract][Full Text] [Related]
42. Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis.
Fan S; Liu X; Liang Y
Gynecol Obstet Invest; 2015; 80(2):113-8. PubMed ID: 25720546
[TBL] [Abstract][Full Text] [Related]
43. Current therapy of vulvovaginitis.
Rein MF
Sex Transm Dis; 1981; 8(4 suppl):316-20. PubMed ID: 7330756
[TBL] [Abstract][Full Text] [Related]
44. Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis.
Droegemueller W; Adamson DG; Brown D; Cibley L; Fleury F; LePage ME; Henzl MR
Obstet Gynecol; 1984 Oct; 64(4):530-4. PubMed ID: 6384848
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of vulvo-vaginal candidiasis with econazole (author's transl)].
Obolensky W; Maire F
Dtsch Med Wochenschr; 1975 Aug; 100(35):1730-3. PubMed ID: 1157671
[TBL] [Abstract][Full Text] [Related]
46. Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.
Simmons KB; Kumar N; Plagianos M; Roberts K; Hoskin E; Han L; Alami M; Creasy G; Variano B; Merkatz R
Contraception; 2018 Mar; 97(3):270-276. PubMed ID: 29097225
[TBL] [Abstract][Full Text] [Related]
47. [Efficacy and tolerance of 200 mg of fenticonazole versus 400 mg of miconazole in the intravaginal treatment of mycotic vulvovaginitis].
Muñoz Reyes JR; Villanueva Reynoso C; Ramos CJ; Menéndez Vázquez J; Bailón Uriza R; Vargas AJ
Ginecol Obstet Mex; 2002 Feb; 70():59-65. PubMed ID: 12017948
[TBL] [Abstract][Full Text] [Related]
48. Effect of butoconazole nitrate 2% vaginal cream and miconazole nitrate 2% vaginal cream treatments in patients with vulvovaginal candidiasis.
Lappin MA; Brooker DC; Francisco CA; Dorfman J
Infect Dis Obstet Gynecol; 1996; 4(6):323-8. PubMed ID: 18476119
[TBL] [Abstract][Full Text] [Related]
49. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.
Guaschino S; De Seta F; Sartore A; Ricci G; De Santo D; Piccoli M; Alberico S
Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459
[TBL] [Abstract][Full Text] [Related]
51. A single-blind comparison of oral and intravaginal treatments in acute and recurrent vaginal candidosis in general practice.
Miller PI; Humphries M; Grassick K
Pharmatherapeutica; 1984; 3(9):582-7. PubMed ID: 6328542
[TBL] [Abstract][Full Text] [Related]
52. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%.
Clin Ther; 1985; 7(5):574-83. PubMed ID: 2865009
[TBL] [Abstract][Full Text] [Related]
53. Fatal toxic epidermal necrolysis associated with use of terconazole vaginal suppository.
Searles GE; Tredget EE; Lin AN
J Cutan Med Surg; 1998 Oct; 3(2):85-7. PubMed ID: 9822781
[No Abstract] [Full Text] [Related]
54. [Terconazole, a new triazole derivative for the treatment of vaginal mycoses].
Raab W
Gynakol Rundsch; 1985; 25(4):197-220. PubMed ID: 4093012
[No Abstract] [Full Text] [Related]
55. Cure rates of oral contraceptive users and non-users when treated for vulvovaginal candidiasis (moniliasis) with miconazole nitrate 2% vaginal cream.
Pasquale SA; Yuliano SE
Contraception; 1977 Mar; 15(3):355-61. PubMed ID: 880814
[No Abstract] [Full Text] [Related]
56. Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream.
Repiso Montero T; López S; Rodríguez C; del Rio R; Badell A; Gratacós MR
Int J Dermatol; 2006 May; 45(5):600-4. PubMed ID: 16700802
[TBL] [Abstract][Full Text] [Related]
57. Development of bifunctional vaginal suppositories by joint use terconazole and probiotic for treatment and prophylaxis of vulvovaginal candidiasis.
Pashayan MM; Hovhannisyan HG
Drug Dev Ind Pharm; 2021 Sep; 47(9):1424-1431. PubMed ID: 34726986
[TBL] [Abstract][Full Text] [Related]
58. [Evaluation of the time response of a single dose administration of fenticonazole nitrate].
Balaïsch J
Contracept Fertil Sex; 1996 May; 24(5):417-22. PubMed ID: 8704823
[TBL] [Abstract][Full Text] [Related]
59. [Damage to condoms caused by vaginally administered drug].
Meyboom RH; Havinga JS; Lastdrager CJ; de Koning GH
Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1602-5. PubMed ID: 7675146
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
